Supernus Pharmaceuticals has announced positive topline results from the Phase III P302 study of SPN-812 in adolescents, for the treatment of attention deficit hyperactivity disorder (ADHD). 21 December 2018
H Spectrum, a Taiwan-based healthcare fund backed by Foxconn, have entered into a memorandum of understanding (MOU) with the German life sciences group Merck KGaA to establish H Spectrum & Merck Innovation Lab. 19 December 2018
The US Food and Drug Administration has appointed Amy Abernethy as principal deputy commissioner, replacing Rachel Sherman, who is retiring. 19 December 2018
UK-based Indivior says it will launch an authorized generic of its Suboxone Film (buprenorphine/naloxone) product, once generic competitors enter the market. 19 December 2018
US-based generics firm Sandoz has agreed a deal with Chinese insulin supplier Gan & Lee to produce biosimilar versions of insulins for type 1 and type 2 diabetes. 19 December 2018
Japan’s largest drugmaker Takeda Pharmaceutical today announced that the listing and trading of its American Depositary Shares (ADSs) on the New York Stock Exchange is expected to commence on December 24, 2018. 19 December 2018
Horizon Discovery Group has entered into an exclusive target discovery partnership with fellow UK-listed firm C4X Discovery, aimed at delivering potential therapies for colorectal and lung cancer. 18 December 2018
Japan’s Taisho Pharmaceutical is reportedly close to agreeing terms with Bristol-Myers Squibb to acquire the company’s French consumer healthcare unit for around $1.6 billion. 18 December 2018
Privately-held X-Chem and Spain's Almirall have agreed to enter into a drug discovery partnership looking for lead compounds in dermatology. 13 December 2018
Spain’s leading drugmaker Almirall has successfully concluded the pricing of its 250 million-euro ($2984 million) in aggregate principal amount of senior unsecured bonds due 2021 conditionally convertible into or exchangeable for new and/or existing ordinary shares of the company. 7 December 2018
UK-based hospital products firm Acacia Pharma says that the US Food and Drug Administration has accepted its resubmission of the New Drug Application (NDA) for Barhemsys (amisulpride injection) as a complete response, addressing the deficiencies identified in the October 5 complete response letter. 7 December 2018
Sandoz Inc, a US division of Swiss pharma giant Novartis, plans to launch Symjepi (epinephrine) 0.3mg Injection in the USA in early first-quarter 2019 for the emergency treatment of allergic reactions (Type 1), including anaphylaxis. 6 December 2018
Despite moves by a small minority of shareholders to derail the deal, a vast majority of shareholders today voted in favor of Japanese drug major Takeda Pharmaceutical’s £46 billion ($58.6 billion) acquisition of Ireland-headquartered rare diseases specialist Shire. 5 December 2018
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024
The Danish Medicines Council (Medicinrådet), responsible for evaluating and recommending new treatments for Denmark’s healthcare system, is facing a significant increase in processing times. 14 October 2024
The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. 14 October 2024
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024